Skip to main content

Biodesix, Inc. (BDSX)

NASDAQ: BDSX · IEX Real-Time Price · USD
5.26 -0.68 (-11.45%)
Dec 3, 2021 4:00 PM EST - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Year202020192018
Revenue
45.5624.5520.43
Revenue Growth
85.55%20.16%-
Cost of Revenue
226.074.41
Gross Profit
23.5618.4816.03
Selling, General & Admin
34.8630.6425.9
Research & Development
10.8210.478.19
Operating Expenses
45.6841.1134.09
Operating Income
-22.12-22.63-18.06
Interest Expense / Income
7.63.012.92
Other Expense / Income
1.635.095.19
Pretax Income
-31.35-30.73-26.17
Net Income
-31.35-30.73-26.17
Net Income Common
-31.35-30.73-26.17
Shares Outstanding (Basic)
500
Shares Outstanding (Diluted)
500
Shares Change
1899.17%21.00%-
EPS (Basic)
-6.48-126.97-130.83
EPS (Diluted)
-6.48-126.97-130.83
Free Cash Flow Per Share
-4.87-95.63-91.47
Gross Margin
51.71%75.26%78.44%
Operating Margin
-48.55%-92.16%-88.40%
Profit Margin
-68.81%-125.15%-128.06%
Free Cash Flow Margin
-51.68%-94.26%-89.54%
EBITDA
-20.84-24.93-21.51
EBITDA Margin
-45.75%-101.52%-105.28%
EBIT
-23.75-27.72-23.25
EBIT Margin
-52.12%-112.90%-113.79%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).